Vertex Kalydeco gets FDA NDA approval
The FDA has also granted the company’s request for six-month Priority Review of Kalydeco, acts by targeting the defective protein that causes CF. The move follows the results
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
Belimumab belongs to a class of drugs known as BLyS-specific inhibitors. The multi-center, international, randomized, double-blind, placebo-controlled, 52-week study will investigate use of belimumab administered subcutaneously (SC) once-weekly